The evolving cannabis industry faces uncertainty under the proposed rescheduling of marijuana under the Controlled Substances Act, potentially impacting medical-use businesses significantly while adult-use businesses may still navigate federal legal constraints. The evolving cannabis industry faces uncertainty under the proposed rescheduling of marijuana under the Controlled Substances Act, potentially impacting medical-use businesses significantly while adult-use businesses may still navigate federal legal constraints. Read More
